We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$38.4B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
-2.96%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$21.8B
AUM Growth
-$767M
(-3.4%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
1,924
New
62
Increased
766
Reduced
660
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Watsco Inc
WSO
|
+$31.3M |
| 2 |
Tyler Technologies
TYL
|
+$24.6M |
| 3 |
Danaher
DHR
|
+$22.7M |
| 4 |
iRhythm Holdings
IRTC
|
+$20.9M |
| 5 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$20.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$77.8M |
| 2 |
Trex
TREX
|
+$39.7M |
| 3 |
DOCU
DocuSign
DOCU
|
+$17.2M |
| 4 |
Akamai
AKAM
|
+$16.6M |
| 5 |
SPDR Gold Trust
GLD
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.15% |
| 2 | Healthcare | 19.33% |
| 3 | Financials | 11.9% |
| 4 | Industrials | 11.25% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Incyte
INCY
$24.3B
| $1.13M | 0.01% |
16,934
-1,742
| -9% | -$129K |
|
777
iShares ESG Aware MSCI USA ETF
ESGU
$18.5B
| $1.13M | 0.01% |
14,185
+447
| +3% | +$39.6K |
|
778
Inspire Medical Systems
INSP
$1.68B
| $1.12M | 0.01% |
6,324
+73
| +1% | +$14.7K |
|
779
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.48B
| $1.12M | 0.01% |
24,297
-238
| -1% | -$11.2K |
|
|
EGRX
780
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.12M | 0.01% |
42,357
| – | – |
|
781
GSK
GSK
$101B
| $1.11M | 0.01% |
+37,792
| New | +$1.43M |
|
782
Virgin Galactic
SPCE
$466M
| $1.11M | 0.01% |
11,793
-689
| -6% | -$88.4K |
|
783
State Street SPDR S&P Semiconductor ETF
XSD
$2.91B
| $1.11M | 0.01% |
7,302
| – | – |
|
|
SBDS
784
DELISTED
Solo Brands Inc
SBDS
| $1.11M | 0.01% |
7,287
-87
| -1% | -$16.3K |
|
785
Civista Bancshares
CIVB
$595M
| $1.11M | 0.01% |
53,300
| – | – |
|
|
WRK
786
DELISTED
WestRock Company
WRK
| $1.11M | 0.01% |
35,822
-200
| -0.6% | -$7.9K |
|
|
SLCA
787
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.1M | 0.01% |
100,712
+1,439
| +1% | +$18.3K |
|
788
WisdomTree US Total Dividend Fund
DTD
$1.7B
| $1.09M | 0.01% |
20,146
-2,160
| -10% | -$129K |
|
789
ProShares Short 20+ Year Treasury ETF
TBF
$106M
| $1.09M | 0.01% |
48,950
-72,895
| -60% | -$1.49M |
|
790
Mettler-Toledo International
MTD
$28.6B
| $1.09M | 0.01% |
1,006
+35
| +4% | +$43.5K |
|
791
Paycom
PAYC
$9.84B
| $1.09M | 0.01% |
3,300
| – | – |
|
792
First Citizens BancShares
FCNCA
$25.7B
| $1.08M | 0.01% |
1,352
-324
| -19% | -$253K |
|
793
National Vision
EYE
$1.51B
| $1.08M | ﹤0.01% |
33,001
+3,429
| +12% | +$111K |
|
794
TriMas Corp
TRS
$1.4B
| $1.06M | ﹤0.01% |
42,311
-1,016
| -2% | -$28K |
|
795
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $1.06M | ﹤0.01% |
11,010
+541
| +5% | +$54.9K |
|
|
XIFR
796
XPLR Infrastructure LP
XIFR
$1.09B
| $1.06M | ﹤0.01% |
14,614
+93
| +0.6% | +$7.45K |
|
797
Schwab U.S Small- Cap ETF
SCHA
$23.5B
| $1.05M | ﹤0.01% |
55,592
+12,430
| +29% | +$260K |
|
798
BRC Group Holdings
RILY
$302M
| $1.05M | ﹤0.01% |
23,503
+7
| +0% | +$350 |
|
|
NATI
799
DELISTED
National Instruments Corp
NATI
| $1.05M | ﹤0.01% |
27,721
+1,988
| +8% | +$75.1K |
|
800
Realty Income
O
$59.6B
| $1.04M | ﹤0.01% |
17,928
+1,207
| +7% | +$83.2K |
|
Similar funds
HF
William Blair & Company's Q3 2022 Portfolio in Review
As of Q3 2022, William Blair & Company held 1,924 positions worth $21.8B, down 3.4% from $22.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
William Blair & Company's Q3 2022 filing shows 62 new, 766 increased, 660 reduced and 101 closed positions. Its largest new stake was GSK: 37,792 shares worth $1.11M. The largest sale was Atlassian, an estimated $77.8M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- William Blair & Company's largest Q3 2022 buy was GSK: 37,792 shares worth $1.11M.
- William Blair & Company added most to Watsco Inc in Q3 2022, an estimated $31.3M increase.
- William Blair & Company's biggest Q3 2022 reduction was Trex, cutting an estimated $39.7M.
- William Blair & Company fully exited Atlassian in Q3 2022, selling an estimated $77.8M.
- William Blair & Company's ten largest holdings make up 23% of its $21.8B portfolio in Q3 2022.
- William Blair & Company opened 62 new positions and closed 101 in Q3 2022.
- William Blair & Company's portfolio value fell 3.4% quarter-over-quarter to $21.8B.
Based on William Blair & Company's 13F filing for Q3 2022, filed 9 Nov 2022.